Skip to main content

Table 5 Prevalence of chronic hepatitis B in the San Francisco Bay area by age and disease status

From: Racial/ethnic- and county-specific prevalence of chronic hepatitis B and its burden in California

Age Group (Years)

Population (2015)

Inactivea CHB

Active HBeAg positive

Active HBeAg negative

Cirrhosis

0–19

2,202,500

1805 (69.2%)

602 (23.1%)

201 (7.69%)

0

20–29

1,254,437

5360 (48.3%)

2744 (24.7%)

2701(24.3%)

300 (2.70%)

30–39

1,311,988

12,218 (50.0%)

4680 (19.2%)

6834 (28.0%)

704 (2.88%)

40–49

1,230,512

13,111 (51.2%)

2930 (11.4%)

7450 (29.1%)

2136 (8.33%)

50–59

1,192,159

9770 (51.1%)

1199 (6.27%)

5154 (27.0%)

2997 (15.7%)

60–69

898,217

7939 (61.4%)

438 (3.38%)

1813 (14.0%)

2751 (21.3%)

70–79

473,888

3186 (52.1%)

382 (6.25%)

1020 (16.7%)

1529 (25.0%)

80+

310,260

1448 (52.1%)

174 (6.25%)

463 (16.7%)

695 (25.0%)

Total

8,873,961

54,837 (52.4%)

13,149 (12.6%)

25,636 (24.5%)

11,112 (10.6%)

  1. aInactive CHB are those who are HBsAg positive with low HBV DNA or high HBV DNA but normal alanine aminotransferase or ALT levels
  2. HBeAg hepatitis B e antigen